New cathepsin V inhibitor from stems of Bowdichia virgilioides
AUTOR(ES)
Silva, Taynara L.
FONTE
Rev. bras. farmacogn.
DATA DE PUBLICAÇÃO
17/10/2019
RESUMO
Abstract Bioassay-guided fractionation of Bowdichia virgilioides Kunth, Fabaceae, extracts has led to the isolation of cathepsin V inhibitors. The investigation of the hexane and ethyl acetate extracts allowed the characterization of eleven compounds: lupeol, lupenone, β-sitosterol and stigmasterol in mixture, trans p-coumaric acid ester derivative, syringaresinol, bowdenol, 8-methoxycoumestrol, 3,4-hydroxy-7-methoxyisoflavone, 7,3′-dihydroxy-4′-methoxyisoflavone, and 5,4′-dihydroxy-7′-methoxyisoflavone. Structures of compounds were stablished by 1D and 2D NMR, and MS experiments. Among the isolated compounds, trans p-coumaric acid ester derivative and 8-methoxycoumestrol showed significant inhibition on cathepsin V, which is up to now unexplored.
Documentos Relacionados
- Anxiolytic-like effect of the extract from Bowdichia virgilioides in mice
- Aspectos fisiolÃgicos da germinaÃÃo de sementes de sucupira-preta (Bowdichia virgilioides Kunth)
- Atividade antimicrobiana do óleo essencial de Bowdichia virgilioides Kunt.
- Anti-inflammatory effect of the ethanolic extract from Bowdichia virgilioides H.B.K stem bark
- Teste de condutividade elétrica em sementes de Bowdichia virgilioides Kunth
